Bgp Healthcare Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is NICOTINE USP, with a corresponding US DMF Number 23485.
Remarkably, this DMF maintains an Active status since its submission on February 07, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 02, 2017, and payment made on February 06, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II